Chemoinformaics analysis of 1-Deacetylnimbolinin B
| Molecular Weight | 584.706 | nRot | 4 |
| Heavy Atom Molecular Weight | 540.354 | nRig | 32 |
| Exact Molecular Weight | 584.299 | nRing | 6 |
| Solubility: LogS | -4.478 | nHRing | 3 |
| Solubility: LogP | 2.903 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 5 |
| nHA | 9 | APOL | 91.6669 |
| nHD | 2 | BPOL | 54.5571 |
| QED | 0.3 |
| Synth | 5.737 |
| Natural Product Likeliness | 3.56 |
| NR-PPAR-gamma | 0.923 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.998 |
| HIA | 0.409 |
| CACO-2 | -5.031 |
| MDCK | 0.0000634 |
| BBB | 0.778 |
| PPB | 0.948558 |
| VDSS | 2.816 |
| FU | 0.0595133 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.207 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.838 |
| CYP2c9-inh | 0.3 |
| CYP2c9-sub | 0.049 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.672 |
| CYP3a4-sub | 0.823 |
| CL | 13.799 |
| T12 | 0.038 |
| hERG | 0.082 |
| Ames | 0.022 |
| ROA | 0.946 |
| SkinSen | 0.025 |
| Carcinogencity | 0.044 |
| EI | 0.006 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.715 |
| Antiviral | Yes |
| Prediction | 0.808333 |